Table 3.
Evaluation methods and data sources for the trans-NIH ACSI project
| Method/Data Source | Primary Content | Planned Coverage (actual n) |
| Review of secondary data | ||
| Website review |
|
All sites (61) |
| ForeSee pre-implementation worksheets |
|
All sites (48) |
| ACSI data for sites generating sufficient response for model data |
|
All sites collecting data during evaluation period: Q4 2004 (8) through Q1 2006 (42) |
| ACSI site-level data aggregated to NIH level |
|
All sites using standard custom question; all sites using similar questions (varied by type of analysis) |
| Surveys | ||
| Initial survey |
|
All sites (57) |
| Final survey |
|
All sites (51) |
| Interviews | ||
| Initial in-depth interview (primary focus: processes) |
|
Subset of sites (14 in 2005; 6 in 2006) |
| Final in-depth interview (primary focus: outcomes) |
|
Subset of sites (20) |
| Final brief interview |
|
Subset of sites with less ACSI experience (5) |
| Observations | Coverage(number of meetings) | |
| Observation of implementation and feedback meetings | How teams:
|
Sample of meeting types – implementation, initial feedback, follow-up feedback (15) |
| Observation of trans-NIH meetings |
|
All trans-NIH meetings (5) |
| Observation of leadership team meetings |
|
Biweekly meetings (all meetings during evaluation period) |